Adlai Nortye ANL
NASDAQ ANL
$15.70 +0.95 (+6.43%)
As of: Sep 4, 2026 · 1:32 PM EDT

Adlai Nortye (ANL) Shares Outstanding (Entity) (2022 - 2025)

Analysis

Adlai Nortye (ANL) Shares Outstanding (Entity) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 214.24 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 575.00 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 218.28 Mn
10 Adlai Nortye 500.40 Mn 268.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 34.34 Mn
Dec 31, 2024 31.24 Mn
Dec 31, 2023 14.45 Mn
Dec 31, 2022 8.48 Mn